Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC02
- Pharmacological subgroupC02D
- Chemical subgroupC02DB
- Chemical substanceC02DB02Hydralazine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 35 registrations
- Apo-Hydralazine25 MG · Tablet · Apotex INC
- Apo-Hydralazine50 MG · Tablet · Apotex INC
- Apo-Hydralazine10 MG · Tablet · Apotex INC
- Hydralazine10 MG · Tablet · Sanis Health INC
United States
FDA · 30 registrations
At a glance
- ATC code
- C02DB02
- ATC group
- Cardiovascular system
- Registers
- 7
- Historical lists
- 1
- Registrations
- 88
- With their own page
- 66
- Companies
- 40
All medicines with Hydralazine
Human medicines from every register that match Hydralazine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
89 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Hydralazine | Canada | 10 MG | Tablet | Marketed | Sanis Health INC |
| Hydralazine | Canada | 25 MG | Tablet | Marketed | Sanis Health INC |
| Hydralazine | Canada | 50 MG | Tablet | Marketed | Sanis Health INC |
| Hydralazine | New Zealand | Tab 25 mg | Funded | ||
| Hydralazine Hydrochloride | United States | 20MG/ML | injectable | Marketed | Smith and Nephew |
| Hydralazine Hydrochloride | United States | 100MG, 10MG, 25MG … | tablet | Marketed | Upsher Smith Labs |
| HYDRALAZINE TABLET 50 mg | Singapore | 50 mg | tablet, film coated | Authorised | Beacons Pharmaceuticals Pte. LTD. |
| HYDRALAZINE TABLETS 10 mg | Singapore | 10 mg | tablet, film coated | Authorised | Beacons Pharmaceuticals Pte. LTD. |
| Hydralazine Hydrochloride Injection, USP | Canada | 20 MG / ML | Solution | Marketed | Auro Pharma INC |
| Hydralazine Hydrochloride Injection, USP | Canada | 20 MG / ML | Solution | Marketed | Eugia Pharma INC. |
| Hydralazine Hydrochloride Injection | Canada | 20 MG / ML | Solution | Authorised | Fresenius Kabi Canada LTD |
| Hydralazine and HydrochlorothiazideCombination | United States | 25MG; 15MG | tablet | Not marketed | Watson Labs |
| Hydralazine Hydrochloride and HydrochlorothiazideCombination | United States | 100MG; 50MG, 25MG; 25MG, 50MG; 50MG | capsule | Not marketed | Solvay |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 25/25Combination | United States | 25MG; 25MG | capsule | Not marketed | Ivax Pharms |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 50/50Combination | United States | 50MG; 50MG | capsule | Not marketed | Ivax Pharms |
| Apo-Hydralazine | Canada | 25 MG | Tablet | Marketed | Apotex INC |
| Apo-Hydralazine | Canada | 10 MG | Tablet | Marketed | Apotex INC |
| Apo-Hydralazine | Canada | 50 MG | Tablet | Marketed | Apotex INC |
| Hydralazine Hydrochloride-Hydrochlorothiazide-ReserpineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Mylan |
| Hydralazine, Hydrochlorothiazide W/ ReserpineCombination | United States | 25MG; 15MG; 0.1MG | tablet | Not marketed | Watson Labs |
| Hydralazine Hydrochloride W/ Hydrochlorothiazide 100/50Combination | United States | 100MG; 50MG | capsule | Not marketed | Ivax Pharms |
| Jamp-Hydralazine | Canada | 10 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Jamp-Hydralazine | Canada | 25 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Jamp-Hydralazine | Canada | 50 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Mint-Hydralazine | Canada | 25 MG | Tablet | Marketed | Mint Pharmaceuticals INC |